KIMBERLY KILPATRICK: Open Payments
NPI 1881146306 · VICKSBURG, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$532 in 27 payments from 15 companies in 2025. Trend: 2023 $566 · 2024 $618 · 2025 $532
Food & beverage: $532
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $88 |
| Grifols USA, LLC | 2 | $65 |
| Amgen Inc. | 3 | $57 |
| Novo Nordisk Inc | 3 | $48 |
| Lundbeck LLC | 2 | $41 |
| GlaxoSmithKline, LLC. | 2 | $40 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $32 |
| Exact Sciences Corporation | 2 | $30 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $26 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $24 |
Products named: Prolastin-C Liquid, REXULTI, OTEZLA, VRAYLAR, TRELEGY ELLIPTA, UBRELVY, JARDIANCE, The Cologuard Plus Collection Kit.
Industry payments across MS — which companies pay providers there.
